Is Abcam (LON:ABC) A Risky Investment?
Warren Buffett famously said, 'Volatility is far from synonymous with risk.' It's only natural to consider a company's...
The Biotech industry has been flat over the last week, but OKYO Pharma has lost 37%. As for the longer term, the industry has declined 42% in the last year. Looking forward, earnings are forecast to grow by 16% annually.
Has the U.K. Biotech Industry valuation changed over the past few years?
Date | Market Cap | Revenue | Earnings | PE |
---|---|---|---|---|
Sat, 28 May 2022 | UK£7.0b | UK£1.1b | -UK£146,804,240.00 | 38.3x |
Mon, 25 Apr 2022 | UK£7.2b | UK£1.1b | -UK£91,620,330.00 | 37.9x |
Wed, 23 Mar 2022 | UK£7.4b | UK£1.1b | -UK£98,687,029.00 | 33x |
Fri, 18 Feb 2022 | UK£8.5b | UK£1.1b | -UK£119,732,737.00 | 35.3x |
Sun, 16 Jan 2022 | UK£9.7b | UK£1.1b | -UK£123,388,341.00 | 47.3x |
Tue, 14 Dec 2021 | UK£11.1b | UK£1.1b | -UK£121,180,343.00 | 54x |
Thu, 11 Nov 2021 | UK£11.9b | UK£1.1b | -UK£149,832,471.00 | 69.8x |
Sat, 09 Oct 2021 | UK£11.8b | UK£1.1b | -UK£148,479,118.00 | 68.8x |
Mon, 06 Sep 2021 | UK£12.9b | UK£1.1b | -UK£143,503,184.62 | 56.7x |
Wed, 04 Aug 2021 | UK£12.1b | UK£1.0b | -UK£172,541,949.91 | 29.6x |
Sat, 08 May 2021 | UK£11.5b | UK£1.0b | -UK£166,311,048.52 | 30.3x |
Tue, 09 Feb 2021 | UK£10.8b | UK£1.0b | -UK£143,994,708.81 | 33.3x |
Mon, 02 Nov 2020 | UK£9.0b | UK£985.1m | -UK£119,804,987.81 | 60x |
Thu, 06 Aug 2020 | UK£8.2b | UK£992.8m | -UK£138,646,257.45 | 54.3x |
Sun, 10 May 2020 | UK£7.1b | UK£985.7m | -UK£114,704,522.81 | 55.7x |
Sat, 01 Feb 2020 | UK£6.4b | UK£946.9m | -UK£63,951,543.44 | 51.5x |
Tue, 05 Nov 2019 | UK£5.7b | UK£925.3m | -UK£83,659,311.30 | 54.1x |
Fri, 09 Aug 2019 | UK£5.9b | UK£898.8m | -UK£94,660,524.01 | 59.6x |
56.9x
How does U.K. Biotech compare with similar industries?
GB Market | 1.04% | |
Healthcare | 2.17% | |
Biotech | 0.71% | |
Biotech | 0.71% |
Which companies have driven the market over the last 7 days?
Company | Last Price | 7D | 1Y | Valuation | |
---|---|---|---|---|---|
ABC Abcam | UK£11.72 | 1.8% +UK£48.0m | -17.2% | PS609.1x | |
AVCT Avacta Group | UK£1.26 | 14.9% +UK£41.6m | -46.7% | PS109.2x | |
GNS Genus | UK£27.34 | 1.9% +UK£32.6m | -45.9% | PS48.2x | |
OXB Oxford Biomedica | UK£5.14 | 4.4% +UK£20.7m | -54.9% | PS26x | |
BVXP Bioventix | UK£37.75 | 5.6% +UK£10.4m | -6.8% | PS29.7x |